Risk factor
Very high price volatility
Profitability factor
Greatly undervalued vs peers
About
DeepVerge plc, an environmental and life science artificial intelligent company, develops and applies AI and IoT technology to analytical instruments for the analysis and identification of bacteria, virus, and toxins. The company offers Labskin, a commercially available lab-grown, full thickness human skin to support product research and development activities in the cosmetic, personal care, medical device, and pharmaceutical sectors; Rinocloud, a data infrastructure as a service that delivers secure intelligent store, share and search, encryption, and infrastructure technologies; and skin trust club, a skin health tracking using advanced sequencing, bioinformatics, and AI algorithms. It also provides regulated environmental toxicology services; human skin equivalent platform to validate and verify the safety and impact on client products for regulatory authority approval; AI and microbiome platform to facilitate clinical trials for skincare companies and remote test-kits for consumer skin; and monitoring and data analytics platform for real-time detection and identification of pathogens in water and wastewater treatment plants, drinking water, rivers, lakes, and reservoirs. In addition, the company offers a range of skin care products and cannabinoid oils. It operates in the United Kingdom, rest of Europe, the United States, and internationally. The company was formerly known as Integumen Plc and changed its name to DeepVerge plc in October 2020. The company was incorporated in 2016 and is headquartered in Malahide, Ireland.
Company Valuation
Considering past and projected metrics, the stock is distinctly 'cheaper' than its peers. Specifically, the stock is underpriced on P/FCF.